Healthcare provider profile · identity verified

Julia A Roulier, MD

Family Practice · BATESVILLE, AR · NPI 1336135805

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	197	45
Amlodipine Besylate	Amlodipine Besylate	176	41
Levothyroxine Sodium	Levothyroxine Sodium	173	39
Pantoprazole Sodium	Pantoprazole Sodium	133	26
Losartan Potassium	Losartan Potassium	127	31
Duloxetine Hcl	Duloxetine Hcl	126	23
Lisinopril	Lisinopril	122	31
Omeprazole	Omeprazole	110	23
Gabapentin	Gabapentin	105	25
Trazodone Hcl	Trazodone Hcl	84	17
Furosemide	Furosemide	80	21
Fluticasone Propionate	Fluticasone Propionate	79	25
Meloxicam	Meloxicam	76	16
Famotidine	Famotidine	72	16
Metoprolol Succinate	Metoprolol Succinate	68	11
Metformin Hcl Er	Metformin Hcl	63	11
Escitalopram Oxalate	Escitalopram Oxalate	62	11
Sertraline Hcl	Sertraline Hcl	62	14
Potassium Chloride	Potassium Chloride	60	suppressed
Bupropion Xl	Bupropion Hcl	56	13
Clopidogrel	Clopidogrel Bisulfate	55	suppressed
Ozempic	Semaglutide	54	11
Alendronate Sodium	Alendronate Sodium	47	12
Alprazolam	Alprazolam	45	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	45	17
Pravastatin Sodium	Pravastatin Sodium	44	11
Rosuvastatin Calcium	Rosuvastatin Calcium	42	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	40	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Pregabalin	Pregabalin	33	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Montelukast Sodium	Montelukast Sodium	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Propranolol Hcl	Propranolol Hcl	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Atenolol	Atenolol	26	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Allopurinol	Allopurinol	22	suppressed
Clonazepam	Clonazepam	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Metformin Hcl	Metformin Hcl	21	suppressed
Simvastatin	Simvastatin	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Imipramine Hcl	Imipramine Hcl	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Eliquis	Apixaban	19	suppressed
Celecoxib	Celecoxib	17	suppressed
Sotalol	Sotalol Hcl	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Carvedilol	Carvedilol	16	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Naproxen	Naproxen	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Wellbutrin Xl	Bupropion Hcl	12	suppressed
Glipizide Er	Glipizide	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Nystatin	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error